2016 CSHP Tracked Legislation
Share |

Click here to download 2016 - August Legislative Update



Bill #

Author

Description

Position

Priority

Status

AB73*

Marie Waldron

HIV/AID treatment (formerly spot bill)

support

3

passed assembly;

scheduled for hearing in SEN Health Committee 6/29/16

AB1114

Eggman

Bill was gutted and amended. Originally a kindergarten evaluation bill, now a CPhA sponsored bill for reimbursement of pharmacist services through MediCal

support

3

ASM Health Committee concurred with Senate Amendment 8/30/16. FInal vote on ASM floor 8/31/16

AB1668

Ian Calderaon

Investigational drugs, biologicals, devices

oppose

3

passed assembly; scheduled for hearing in SEN Health Committee 6/22/16

AB1696

Chris Holden

MediCal tobacco cessation services

support

3

passed assembly; scheduled for hearing in SEN Health Committee 6/22/16

AB1831

Evan Low

Healthcare coverage, prescriptions, refills

support

3

amended 6/9/16; passed assembly; scheduled for hearing in SEN Health Committee 6/22/16

AB2084

Jim Wood & Jeff Stone

MediCal-comprehensive med management

support

1

no activity since 5/27/16; stuck in Assembly Appropriations Committee

SB1193

Jerry Hill

BOP sunset provision extension

support

3

passed both houses and enrolled. being sent to Governor

SB 1217

Jeff Stone

DCA reporting of damage awards requirements

support

3

stuck in SEN Business, Professions, & Economic Dev Committee since April

SB1229

Jackson and Stone

Pharmacies, secure takeback bins

support

3

amended 6/14/16; passed senate; scheduled for hearing in ASM Judiciary Committee 6/21/16

SB1346

Ben Allen

Drug labeling, med guides, electronic delivery

support

3

Dead; has not passed first committee, hearing cancelled by author

SCR109

Jeff Stone

California Pharmacists Outreach Week

support if amended

1

passed and chaptered by the Secretary of State on 5/4/16

HR592

Brett Guthrie, G. K. Butterfield, & Todd C. Young

Pharmacists, Medicare Part B

support

1

no action since Feb 2015; has 288 co-sponsors (66% of House)

S314

Robert P. Casey, Mark Kirk, & Sherrod Brown

Pharmacists, Medicare Part B

support

1

no action since Jan 2015; has 47 co-sponsors (47% of Senate) Sen Boxer is a co-sponsor

CCR1715.65

BOP

Reconciliation & Inventory of Controlled Substances

oppose unless amended

2

referred to Enforcement Committee for review

CCR 1746.5

BOP

Travel medications

support

3

currently under review by the Dept of Consumer Affairs; expect action soon

 


Bill Analysis Report 

 

California Society of Health-System Pharmacists

Government Affairs Advisory Committee

Bill Number: AB 73         

 

Author: Marie Waldron (R-Escondido)   

 

Sponsor: Marie Waldron (R-Escondido)

 

Date Bill Introduced:     

Introduced 12/18/2014

Last Amended 1/5/16

Passed Assembly (77-0-2) on 1/25/2016               

 

Subject: Patient Access to Prescribed Antiretroviral Drugs for HIV/AIDS treatment Act   

 

Summary (What does this bill do):         

This bill, to the extent permitted by federal law, would provide that if medically necessary antiretroviral drugs used in the treatment of HIV/AIDS is prescribed by a Medi-Cal beneficiary's treating provider for that purpose, and coverage for that prescribed drug is denied by a Medi-Cal managed care plan in which the beneficiary is enrolled, that denial shall be reviewed in accordance with the bill. This bill would provide that if the treating provider demonstrates, consistent with federal law, that in his or her reasonable, professional judgment, the drug is medically necessary and consistent with the federal Food and Drug Administration's labeling and use rules and regulations, as specified, the beneficiary would be entitled to an automatic urgent appeal.  An urgent appeal shall be resolved by the plan within 24 hours after the plan receives the request. 

 

Support: None (Previous Support: American Nurse Association\California, Biocom, California Chronic Care Coalition, California Healthcare Institute)

 

Opposition: None (Previous Opposition: California Association of Health Plans, Health Access California)

 

Analysis:  Through the various amendments and alterations to the bill since its introduction, the scope of the legislation has been greatly diminished.  The bill now solely addresses antiretroviral medications prescribed for HIV treatment and denied by Medi-Cal.  The current appeal process is defined as lasting 72 hours and this bill, if passed, would shorten that appeal timeframe to 24 hours.  While the shortening of the review period is important to a patient and his/her care and preventing treatment gaps would lessen the risk of resistance mutations, the impact of a quicker appeal process would have little impact on the day to day activity of the profession of pharmacy.

 

Recommended Position (Support, Oppose, Watch):   Support

 

Recommended Priority (1-3):    Priority 3

                       

Bill Contact: Andrea Gutierrez (916) 319-2075 (Capital Office)

                       

Report Prepared by: Chris Mapes            

 

Date: 3/8/16      

 

 

Bill Analysis Report 

 

California Society of Health-System Pharmacists

Government Affairs Advisory Committee

 

Bill Number:      AB 1668

 

Author: Ian Calderaon (D-Whittier)

 

Sponsor:              None

 

Date Bill Entered:            Date formally introduced             1/15/2016            Original

 

Subject:               Access to investigational drugs, biologics or devices for patients with life-threatening conditions

 

Digest:  Permits a manufacturer of an investigational drug, biological product, or device to make the product available to eligible patients with life-threatening conditions. Authorizes a health benefit plan to provide coverage for any investigational drug, biological product, or device. Prohibits disciplinary action against any physician for a related recommendation. Prohibits using such recommendation as the basis for excluding a physician from Medicaid or Medicare certification.

 

Analysis:

·      “Right to Try” Bill

·      Similar bill was vetoed by Governor last year

·      Under current FDA law patients are prohibited from having access to investigational drugs unless approved by an special express approval, however there is often delay in the process which terminally ill patients cannot wait for. This law would bypass FDA regulation.

·      May expose patients to unapproved and unregulated drugs

·      Pharmacists may be caught in the middle providing drugs with little or known safety or therapeutic information

·      Weakens the authority of the FDA to regulate drugs

 

Contact:              

 

Position:              Support                Consumer Groups

                       

                                Oppose               

      • CMA initially opposed, but has withdrawn after protections for providers was added
      • CNA
      • PharMA
        Oncologist groups

 

Recommended Position:             Oppose

 

Recommended Priority:               3

 

Report Prepared by:       Thomas Pugh

 

Date:     3/4/2016

 

 

 

Bill Analysis Report 

California Society of Health-System Pharmacists

Government Affairs Advisory Committee Bill Report Form

Bill Number:      AB 1696

Author: ASM Chris Holden (D) district 41

Sponsor:              TBD

Date Bill Entered:            Date formally introduced             1/21/16

Subject:               Tobacco Cessation Services

Digest:  This bill would provide that, only to the extent that federal financial participation is available and not otherwise jeopardized, and any necessary federal approvals have been obtained, tobacco cessation services are covered benefits, subject to utilization controls, under the Medi-Cal program and would require those services to include all intervention recommendations, as periodically updated, assigned a grade A or B by the United States Preventive Services Task Force, and, at a minimum, 4 quit attempts per year. The bill would also require, only to the extent consistent with the recommendations of the United States Preventive Services Task Force, tobacco cessation services to include at least 4 counseling sessions per quit attempt and a 12-week treatment regimen of any medication approved by the federal Food and Drug Administration for tobacco cessation. The bill would require the department to seek any federal approvals necessary to implement those provisions

Analysis:

· This bill would require that smoking cessation programs covered by MediCal be consistent with established federal standards

Contact:  Victor Munoz  victor.munoz@asm.ca.gov

Position:              Support                TBD

                                Oppose                                TBD

Recommended Position:             Support

Recommended Priority:               3

Report Prepared by:       Keith Yoshizuka

Date:     3/10/16

 

 

 

Bill Analysis Report 

California Society of Health-System Pharmacists

Government Affairs Advisory Committee

Bill Number: AB 1977 Health Coverage, Abuse Deterrent Opioid Analgesics

Author: Jim Wood and Waldorn

Sponsor: Unknown        

Date Bill Introduced: 2/16/16                    

Subject: Allowing abuse deterrent opioid analgesics to be covered on formulary by health insurance companies as part of the Insurance Code and Health and Safety Code               

Summary (What does this bill do): The bill requires individual or group healthcare services or disability insurance policies issued, amended, or renewed after 1/1/16 which provide coverage for opioid analgesics to cover on formulary at least one abuse deterrent opioid analgesics per opioid analgesic active ingredient. The bill also prohibits requiring the patient to try a non-abuse-deterrent opioid analgesic before receiving coverage for the abuse deterrent opioid analgesic. The co-pay for brand name products should not exceed the lowest cost-sharing of the brand name product. Also, the bill will impose a state-mandated local program to make willful violation of the bill’s requirements a crime.

Analysis (Your thoughts about the bill):

  • The bill addresses a solution to the need for safer distribution and use of opioid analgesics.
  • The bill mandates that the cost of the abuse-deterrent opioid analgesic not be increased to greater than the lowest-cost sharing price.
  • The bill allows patient to avoid the risk of addiction and abusing opioids by prohibiting requiring he/she to try a non-abuse-deterrent product first.
  • The bill does not specify what tier the abuse deterrent opioid analgesics will be.
  • The bill does not specify the funding and resources to be used to enforce this bill.

Recommended Position (Support, Oppose, Watch): Support

Recommended Priority (1-3): 3

Bill Contact: Tony.Bui@asm.ca.gov; (707) 463-5770

Report Prepared by: Ronika Kalpage      

Date: 3/9/16

 

Bill Analysis Report 

California Society of Health-System Pharmacists

Government Affairs Advisory Committee

Bill Number:      AB 2084

Author: Jim Wood (D-Eureka) and Jeff Stone

Sponsor:              CPhA    

Date Bill Entered:            Date formally introduced            2/17/2016

Subject:               Coverage of comprehensive medication management (CMM) under Medi-Cal

Digest:  CMM services be a covered benefit under Medi-Cal and require development and implementation of a written medication treatment plan to resolve medication therapy problems and to prevent future medication therapy problems. The department will evaluate the effectiveness of CMM on quality of care, patient outcomes, and savings generated.

Analysis:

·         Beneficial for managing polypharmacy

·         Reduces DDI including herbal medications and OTCs

·         Increases compliance

·         Reduces readmission costs

·         Pharmacists be able to bill Medi-Cal for CMM services provided

·         Retail pharmacists have little time to provide CMM services

·         Increases demand for pharmacists

Contact:            Liz Snow liz.snow@asm.ca.gov

Position:              Support               

                Oppose                CA Association of Health Plans has a position of “Watch” at this time

Recommended Position:  Support

Recommended Priority:   1

Report Prepared by:       Lily Zheng

Date:     3/9/2016

 

 

Bill Analysis Report 

 

California Society of Health-System Pharmacists

Government Affairs Advisory Committee

 

Bill Number:      SB 1193

 

Author: ASM Jerry Hill (D) District 13

 

Sponsor:              Author sponsored

 

Date Bill Entered:            Date formally introduced             2/18/16 Original

 

Subject:               California State Board of Pharmacy:  executive officer

 

Digest:  The Board of Pharmacy is subject to a sunset clause; currently January 1, 2017.  This bill would extend the existence of the Board of Pharmacy until January 1, 2021.

 

Analysis:

·      The California State Board of Pharmacy performs a useful function in this state

·      The costs of doing business for the Board of Pharmacy is covered entirely by fee collected.  No tax revenues are allocated to fund the Board of Pharmacy

·      The Board of Pharmacy has supported and collaborated with CSHP in the past to achieve mutually aligned goals

               

Contact:               Sarah Mason, Senate Business & Professions Committee

                Sarah.mason@sen.ca.gov,          (916) 651-4104

 

Position:              Support                none on record yet

               

                                Oppose                                none on record yet

 

Recommended Position:             Support

                               

Recommended Priority:      3

 

Report Prepared by:       Keith Yoshizuka

 

Date:     3/3/16

 

 

 

 

 

 

 

 

 

Bill Analysis Report 

 

California Society of Health-System Pharmacists

Government Affairs Advisory Committee

 

Bill Number:      SB 1217

 

Author: SEN Jeff Stone (R) 28th district

 

Sponsor:              Author sponsored

 

Date Bill Entered:            Date formally introduced             2/18/16 Original

 

Subject:               Healing arts:  reporting requirements:  professional liability

 

Digest:  Existing law requires that the individual historical record contain any reported judgment or settlement requiring the licensee or the licensee’s insurer to pay over $3,000 in damages for any claim that injury or death was proximately caused by the licensee’s negligence, error or omission in practice, or rendering unauthorized professional service. This bill would instead require the record to contain reported judgments or settlements with damages over $10,000.

Analysis:

·      This statute was developed in the 1960s.  Since that time, inflation has occurred (gasoline used to be 19¢ per gallon in the 1960s

·      $10,000 is the new $3,000.  It is not unusual to dispose of nuisance suits because the costs of litigation exceed $10,000.

·      Any significant claim for damages will exceed $10,000 in damage awards

               

Contact:               Bijan Mehryar

                Bijan.mehryar@sen.ca.goiv, 916-651-4028

 

Position:              Support                none on record yet

               

                Oppose                none on record yet

 

Recommended Position:             Support

 

Recommended Priority:      3

 

Report Prepared by:       Keith Yoshizuka

 

Date:     3/3/16

 

 

 

 

 

 

 

Bill Analysis Report 

 

California Society of Health-System Pharmacists

Government Affairs Advisory Committee

 

Bill Number: SB 1346     

 

Author: Ben Allen           

 

Sponsor: Ben Allen (D 26th district)          

 

Date Bill Introduced: 03/03/2016 Mar. 3 Referred to Com. on B., P. & E.D.

 

Subject:  Pharmacists: Drug Labeling: medication guides: electronic delivery       

 

Summary (What does this bill do): 

 

This bill would authorize a pharmacist to offer to a patient, as an alternative to a printed paper medication guide for a prescription drug as required by the United States Food and Drug Administration, the electronic delivery of the medication guide. The bill would authorize a pharmacist to deliver the medication guide by electronic means if the patient chooses electronic delivery.

 

Support: None 

 

Oppose: None

 

Analysis:  The production and mandated furnishing of a Medication Guide is an essential tenant of protecting public health.  An ability to provide an electronic copy of this information directly to a receptive patient would greatly facilitate the education of that patient and could lead to a more informed patient/public.  From a business perspective, this bill would allow the reduction of printing efforts/cost within the pharmacy and increase connectivity between the patient and pharmacists as the patient would have to supply an active email address to participate in the e-delivery of this information.  Workflows could be further positively impacted if the delivery process was automated.  I feel that CSHP should support this piece of legislation and educate its membership to the delivery options it may or may not produce for them in the future.

 

Recommended Position (Support, Oppose, Watch): Support

 

Recommended Priority (1-3): Priority 2

               

Bill Contact:       Josh Cohen

                Josh.Cohen@sen.ca.gov

                (916) 651-4026 (Capital Office)

               

Report Prepared by: Chris Mapes            

 

Date: 3/7/16      

 

 

Bill Analysis Report 

 

California Society of Health-System Pharmacists

Government Affairs Advisory Committee Bill Report

 

Bill Number:      SCR-109

 

Author: Senator Jeff E. Stone

 

Sponsor:              California Pharmacists Association,

                                Supannee Lertpaichaiyon (Touro P2 student in Senator Stone’s district))

 

Date Bill Entered:            February 12, 2016                            X             Original

 

Subject:               California Pharmacists Outreach Week

 

Digest:  To declare California Pharmacist Outreach Week annually starting February 12, 2016 to February 21, 2016 and thereafter where student pharmacists may be able to perform outreach and preventative services to the community, which includes, but not limited to health fairs, blood drives, preventative education and poison prevention. Events will target health conditions such as (not all inclusive) hypertension, diabetes, high cholesterol, tobacco cessation, immunizations, and reproductive health.

 

Analysis:

· This bill may potentially increase pharmacy student outreach by dedicating awareness in the patient community.

· In the student level, ASHP advocates for students to design and implement activities promoting pharmacists’ interventions and activities that may impact patient outcomes. These include, but not limit to influenza immunization initiative, anticoagulation resource for patients, and antimicrobrial practices. The purpose of these events is to acquaint students early in education to not only provide services to the community, but to undertake roles and responsibilities as they enter into practice post-graduation.

· There is little opposition to the bill as currently pharmacy students from California have been participating in outreach events.

 

Contact:                  Brittny Garcin  Email: brittny.garcin@sen.ca.gov

 

Position:              Support                California Pharmacists Association

                       

                                Oppose                                None

 

Recommended Position:             Support if amended.  The bill has already passed the senate but is stuck in the assembly because the date of the declaration has already passed.  We would recommend that the bill be amended to declare the third week of February annually as California Pharmacists Outreach Week.

                                               

Recommended Priority:               Priority 1

 

Report Prepared by:       Jasmine Reber

 

Date:     March 4, 2016

 

 

 

 

 

Bill Analysis Report 

 

California Society of Health-System Pharmacists

Government Affairs Advisory Committee

 

Bill Number: HR 592

 

Authors: Brett Guthrie (R. KY-2), G. K. Butterfield (D. NC-1), & Todd C. Young (R. IN-9)   

 

Sponsor: APhA, NCPA, NACDS)

 

Date Bill Introduced: January 28, 2015                   

 

Subject:  To amend Title XVIII of the Social Security Act (Medicare) to cover pharmacist services

 

Summary:

HR 592, Pharmacy and Medically Underserved Areas Underserved Enhancement Act will amend

Title XVIII of the Social Security Act to allow pharmacist services as legally authorized by the

State in underserved areas of primary care physicians (defined by Public Health Services Act) to be covered by Medicare. These services would otherwise be covered when performed by physicians.

 

Analysis: This bill would expand health services to specifically to the underserved areas in

California of where there is an insufficient supply of primary care providers to meet the demand

of patients. There are minimal costs for development or implementation as the Board of

Pharmacy and the Medical Board of California are establishing pharmacists’ services under SB

493. To facilitate implementation, the Secretary of Human Health Services shall designate pharmacist specific codes under the physician fee schedule of the Social Security Act.

 

HR 592 currently has 269 co-sponsors.  There are 435 members in the House of Representatives.  Therefore, at 61.8%, it has enough votes to pass the House.  However, there are only 41 cosponsors of S 314 on the senate side (out of 100 senators).

 

Supported by the Patient Access to Pharmacists’ Care Coalition, who is composed of:  Albertson’s LLC and New Albertson’s Inc.,,American Association of Colleges of Pharmacy, American Pharmacists Association, American Society of Consultant Pharmacists, American Society of Health-System Pharmacists, AmerisourceBergen, Association of Clinicians for the Underserved, BI-LO Pharmacy, Cardinal Health, CVS Health, Food Marketing Institute, Fred’s Pharmacy, Fruth Pharmacy, Healthcare Distribution Management Association, Healthcare Leadership Council, Hematology/Oncology Pharmacy Association, International Academy of Compounding Pharmacists, Kroger, McKesson, National Alliance of State Pharmacy Associations,
National Association of Chain Drug Stores, National Center for Farmworker Health, National Community Pharmacists Association, National Consumers League, National Patient Advocate Foundation, National Pharmaceutical Association, National Rural Health Association, Omnicell
Pediatric Pharmacy Advocacy Group, Rite Aid Pharmacy, Safeway, SUPERVALU Pharmacies, Target, Thrifty White Pharmacy, Walgreens, WalMart, Winn-Dixie Pharmacy,

 

Recommended Position: Support

 

Recommended Priority (1-3): 1

                       

Bill Contact:  Naomi Mitchell, (301) 664-8657, NMichaelis@ashp.org,

                       

Report Prepared by: Keith Yoshizuka/Jasmine Reber     

 

Date: 03/03/16 

Bill Analysis Report 

 

California Society of Health-System Pharmacists

Government Affairs Advisory Committee

Bill Number: S 314

 

Authors: Robert P. Casey (Dem-PA), Mark Kirk (Rep-IL), & Sherrod Brown (Dem-OH)    

 

Sponsor: American Pharmacists Association (APhA), National Community Pharmacists Association (NCPA), National Association of Chain Drug Stores (NACDS)           

 

Date Bill Introduced: January 29, 2015                   

 

Subject:  Companion bill to HR 592 to amend Title XVIII of the Social Security Act (Medicare) to

cover pharmacist services

 

Summary:

Both HR 592 and S 314, the Pharmacy and Medically Underserved Areas Underserved

Enhancement Act will amend Title XVIII of the Social Security Act to allow pharmacist services as

legally authorized by the State in underserved areas of primary care physicians (defined by

Public Health Services Act) to be covered by Medicare. These services would otherwise be

covered when performed by physicians.

 

Analysis: This bill would expand health services to specifically to the underserved areas in

California of where there is an insufficient supply of primary care providers to meet the demand

of patients. There are minimal costs for development or implementation as the Board of

Pharmacy and the Medical Board of California are establishing pharmacists’ services under SB

493. To facilitate implementation, the Secretary of Human Health Services shall designate pharmacist specific codes under the physician fee schedule of the Social Security Act.

 

HR 592 currently has 269 co-sponsors.  There are 435 members in the House of Representatives.  Therefore, at 61.8%, it has enough votes to pass the House.  However, there are only 41 cosponsors of S 314 on the senate side (out of 100 senators).

 

Supported by the Patient Access to Pharmacists’ Care Coalition, who is composed of:  Albertson’s LLC and New Albertson’s Inc.,,American Association of Colleges of Pharmacy, American Pharmacists Association, American Society of Consultant Pharmacists, American Society of Health-System Pharmacists, AmerisourceBergen, Association of Clinicians for the Underserved, BI-LO Pharmacy, Cardinal Health, CVS Health, Food Marketing Institute, Fred’s Pharmacy, Fruth Pharmacy, Healthcare Distribution Management Association, Healthcare Leadership Council, Hematology/Oncology Pharmacy Association, International Academy of Compounding Pharmacists, Kroger, McKesson, National Alliance of State Pharmacy Associations, National Association of Chain Drug Stores, National Center for Farmworker Health, National Community Pharmacists Association, National Consumers League, National Patient Advocate Foundation, National Pharmaceutical Association, National Rural Health Association, Omnicell, Pediatric Pharmacy Advocacy Group, Rite Aid Pharmacy, Safeway, SUPERVALU Pharmacies, Target, Thrifty White Pharmacy, Walgreens, WalMart, Winn-Dixie Pharmacy,

 

Recommended Position: Support

 

Recommended Priority (1-3): 1

                       

Bill Contact:  Naomi Mitchell, (301) 664-8657, NMichaelis@ashp.org,

                       

Report Prepared by: Keith Yoshizuka/Jasmine Reber    

 

Date: 03/03/16 

Bill Analysis Report 

 

California Society of Health-System Pharmacists

Government Affairs Advisory Committee

 

Bill Number:      CCR 1715.65

 

Author: California Board of Pharmacy

 

Sponsor:              California Board of Pharmacy

 

Date Regulation Entered:            Text Approved by Board July 29, 2015,  

Initial Statement of Reasons       October 16, 2015 Original

 

Subject:               Reconciliation and Inventory Report of Controlled Substances

 

Digest:  This proposal will require pharmacies and clinics licensed under BPC sections 4180 or 4190 to perform, at minimum, a quarterly physical count inventory of all Schedule II controlled substances and at least one additional controlled substance as identified by the Board based on drug loss reports. Also mandates a pharmacy develop policies and procedures for inventories and reconciliations.

 

Analysis:

·         Requires a physical count of all Schedule II controlled substances and at least one other controlled substance as determined by the Board of Pharmacy

·         Requires the PIC in a pharmacy, or the consultant pharmacist for a clinic, to review all controlled substance reconciliations and inventories, and to establish and maintain secure methods to prevent loss of controlled substances. 

·         Written policies and procedures must be developed that ensure consistency of reconciliation and inventory processes

·         The feasibility of hospitals and health systems to be able to reconcile administration and purchase of thousands of doses in not reasonable.

·         In systems with a perpetual inventory would touching the medication and performing a count at least every 3 months count or would the entire stock have to be inventoried on the same day?

·         Cedars-Sinai Medical Center and I recommend that the BOP focus on requiring hospitals to create robust controlled substance surveillance programs that include retrospective and prospective review of controlled substance purchases, administrations and waste..  Such a program should include audits of inpatient, outpatient and procedural areas.  It should encompass audits of nursing, physician and pharmacy staff.  The program should use existing tools available through automated dispensing cabinet vendors and other surveillance program vendors.  Requiring such programs in hospitals would be similar to the requirement that a hospital have an antimicrobial stewardship program.

 

Recommended Position:             Oppose unless amended; regulation is designed for retail pharmacies.  Does not account for complexities of hospitals

                                               

Recommended Priority:               2

 

Report Prepared by:       Robert Stein and Karen Craddick

 

Date:     3/8/2016

 

 

Bill Analysis Report 

 

California Society of Health-System Pharmacists

Government Affairs Advisory Committee

 

Bill Number:      CCR1746.5

 

Author: California Board of Pharmacy

 

Sponsor:             

 

Date Bill Entered:            Date formally introduced             6/04/2015

 

Subject:               Changes to the requirements of pharmacists for furnishing travel medications

 

Digest:  Documentation for a pharmacist who furnishes travel medications shall be kept on site and available for inspection by the Board includes immunization certificate, completion of 10-hour travel medicine training program covering each medication related element of the International Society of Travel Medicine’s Body of Knowledge for the Practice of Travel Medicine, completion of the CDC Yellow Fever Vaccine Course, and BLS certification. Pharmacist shall notify patient’s PCP within 30 days of furnishing travel medications or devices.

 

Analysis:

·  Time period to notify PCP changed from 90 days to 30 days.

·  Travel medicine training program hours changed from minimum 20 hours to 10 hours

·  Travel medicine training programs focuses on “medication related” elements.

·  Changed “completion of an approved immunization training program” to “completion of an immunization certification program that meets the requirements of Business and Professions Code section 4052.8(b)(1).”

 

Contact:

 

Position:              Support                9 members of the CA BOP at the January 2016 meeting

                                Oppose                                0 members of the CA BOP

 

Recommended Position:             support               

 

Recommended Priority:      3

 

Report Prepared by:       Lily Zheng

 

Date:     3/9/2016

 

 

 

 

 

 

 

Contacts

California Society of Health-System Pharmacists
1314 H Street, Suite 200
Sacramento, CA 95814
Office: (916) 447-1033
Fax: (916) 447-2396
Email: info@cshp.org
Hours: M-F 8:00am – 5:00pm

Connect